Article
Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphoma.
HLA - 1 Jun 2024
Morishima Satoko, Yoshimitsu Makoto, Shindo Takero, Utsunomiya Atae, Ishida Takashi, Ito Ayumu, Nakano Nobuaki, Kawakita Toshiro, Eto Tetsuya, Suehiro Youko, Itonaga Hidehiro, Mori Yasuo, Miyazaki Yasuhiko, Kanda Junya, Uchida Naoyuki, Sawayama Yasushi, Tomori Shouhei, Ichinohe Tatsuo, Atsuta Yoshiko, Fukuda Takahiro, Kato Koji
Abstract excerpt
Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for adult T-cell leukaemia/lymphoma (ATL). Specific HLAs are associated with outcomes of immunotherapy and allo-HSCT. We hypothesised that individual HLAs would affect the clinical outcomes of ATL patients after allo-HSCT. Using data from a Japanese registry, we retrospectively analysed 829 patients with ATL who received...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
